Covered recipient · General Payments record
PAUL EHRLICH
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecology
General Payments · PY2018–2023
$1,039.10
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.90 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $139.38 | 8 |
| Acerta Pharma LLC | $112.26 | 1 |
| Amgen Inc. | $112.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $112.26 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020052917 | CMS |
| AstraZeneca Pharmaceuticals LP | $112.26 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1061178171 | CMS |
| GlaxoSmithKline, LLC. | $23.58 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003356899 | CMS |
| GlaxoSmithKline, LLC. | $88.45 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003356911 | CMS |
| GlaxoSmithKline, LLC. | $0.68 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003355329 | CMS |
| GlaxoSmithKline, LLC. | $1.66 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003356887 | CMS |
| GlaxoSmithKline, LLC. | $18.58 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003354547 | CMS |
| GlaxoSmithKline, LLC. | $2.99 | 10/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003357557 | CMS |
| GlaxoSmithKline, LLC. | $0.83 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003355325 | CMS |
| GlaxoSmithKline, LLC. | $2.61 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003356895 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.